Diabetes and Neurogenic Bladder
Links shared publicly online about this topic
Managing Recurrent UTIs in the Patient With Neurogenic Bladder : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on June 15, 2011 at 4:32 pm By:
Bob Finn - Medical News Net Health News
Managing Recurrent UTIs in the Patient With Neurogenic Bladder http://bit.ly/jD532H
Pediatrics Medical News about Urinary Bladder, Neurogenic
mdlinx.com — “The Effect of Epigenetic Therapy on Congenital Neurogenic Bladders : A Pilot Study” View full resource at mdlinx.com
Most Recently Shared on February 9, 2010 at 1:34 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Peds: The Effect of Epigenetic Therapy on Congenital Neurogenic Bladders : A Pilot Study: Urology http://bit.ly/ctb3Wu
Infectious Disease Article | Urinary Bladder, Neurogenic
mdlinx.com — “Multicenter Randomized Controlled Trial of Bacterial Interference for Prevention of Urinary Tract Infectionin Patients With Neurogenic Bladder” View full resource at mdlinx.com
Most Recently Shared on July 6, 2011 at 3:54 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Multicenter Randomized Controlled Trial of Bacterial Interference for Prevention of Urinary Tract Infectioni... http://bit.ly/pSZc6h #ID
Neurogenic Bladder Disorders: Neither Benefit Nor Harm Proven In Use Of L-Methionine
medicalnewstoday.com — “It is unclear whether patients with neurogenic bladder disorders benefit from the drug L-methionine. The only study currently available provides neither proof of benefit nor proof of harm. This is” View full resource at medicalnewstoday.com
Most Recently Shared on July 20, 2010 at 4:05 pm By:
Neurogenic Bladder Disorders: Neither Benefit Nor Harm Proven In Use Of L-Methionine http://mnt.to/3Gm2 #urology
New Bladder Cancer Warning for Diabetes Drug ActosNew Bladder Cancer Warning for Diabetes Drug Actos
webmd.com — “The FDA has issued a new warning of increased bladder cancer risk associated with use of the diabetes drug Actos (pioglitazone).” View full resource at webmd.com
Most Recently Shared on June 16, 2011 at 2:31 pm By:
Jane Anderson Healthy Eating Advisor
New Bladder Cancer Warning for Diabetes Drug Actos http://bit.ly/lTdbMk
New Bladder Cancer Warning for Diabetes Drug ActosNew Bladder Cancer Warning for Diabetes Drug Actos
webmd.com — “The FDA has issued a new warning of increased bladder cancer risk associated with use of the diabetes drug Actos (pioglitazone).” View full resource at webmd.com
Most Recently Shared on June 16, 2011 at 3:38 pm By:
FDA warns Actos increases bladder cancer risk after long-term use. http://bit.ly/m3NhfC
Management of Patients With a Neurogenic Bladder Secondary to Spinal Cord Injury - QualityPoint Technologies
qualitypointtech.net — “How are patients with a neurogenic bladder secondary to spinal cord injury managed, both initially and long term? Medscape Urology” View full resource at qualitypointtech.net
Most Recently Shared on August 13, 2010 at 5:24 pm By:
Management of Patients With a Neurogenic Bladder Secondary to Spinal Cord Injury: How are patients with a neurogen... http://bit.ly/aBCVSs
Clinical Trial: Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder (ACCEPTANCE) - Renal and Urology News
renalandurologynews.com — “A look at the following clinical trial: Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder (ACCEPTANCE)” View full resource at renalandurologynews.com
Most Recently Shared on July 26, 2010 at 8:40 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Clinical Trial: Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder (ACC... http://bit.ly/9IA1u2
Urologic complications of the neurogenic bladder. [Urol Clin North Am. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on October 25, 2010 at 4:18 am By:
Urologic complications of the neurogenic bladder.: Authors: Gormley EA Patients with a neurogenic bladder are ... http://bit.ly/aOuvST
L-methionine in patients with neurogenic bladder disorders: neither benefit nor harm proven
physorg.com — “It is unclear whether patients with neurogenic bladder disorders benefit from the drug L-methionine. The only study currently available provides neither proof of benefit nor proof of harm. This is the result of a report published by the German Institute for Quality and Efficiency in Health Care (IQWiG) ...” View full resource at physorg.com
Most Recently Shared on July 19, 2010 at 4:00 pm By:
PhysOrg Health News Health News
L-methionine in patients with neurogenic bladder disorders: neither benefit nor harm proven http://tw.physorg.com/198758634
More signs diabetes drug linked to bladder cancer | Reuters
reuters.com — “NEW YORK (Reuters Health) - A review of official reports of bad drug reactions is revealing more signs that people taking the diabetes drug Actos are at higher risk of developing bladder cancer.Between” View full resource at reuters.com
Most Recently Shared on May 13, 2011 at 9:38 pm By:
More signs diabetes drug linked to bladder cancer http://reut.rs/jaPmMm
Dapagliflozin Raises Breast And Bladder Cancer Risk In Diabetes Patients
medicalnewstoday.com — “Experimental diabetes medication - dapagliflozin - was found to raise the risk of developing breast and bladder cancers, researchers reported at the American Diabetes Association meeting, San Dieg” View full resource at medicalnewstoday.com
Most Recently Shared on June 26, 2011 at 12:05 am By:
Dapagliflozin Raises Breast And Bladder Cancer Risk In Diabetes Patients http://mnt.to/3XFC #healthnews
FDA: Diabetes drug Actos linked to bladder cancer
healthcare.tweetmeme.com — “All the news on healthcare” View full resource at healthcare.tweetmeme.com
Most Recently Shared on September 19, 2010 at 9:52 am By:
Healthcare TweetMeme Health Social Media
FDA: Diabetes drug Actos linked to bladder cancer http://retwt.me/1OQbw (via @wisdeo)
Common type 2 diabetes medication may raise risk of bladder cancer
endocrineweb.com — “The type 2 diabetes medication pioglitazone may be associated with an increased risk of bladder cancer, according to a new review of Food and Drug Administration data conducted by a team of Italian researchers.” View full resource at endocrineweb.com
Most Recently Shared on May 23, 2011 at 5:39 pm By:
Common type 2 diabetes medication may raise risk of bladder cancer http://dlvr.it/SjxJ2
Diabetes Drug Actos May Increase Risk of Bladder Cancer | diabetes
diabeticlive.com — “Takeda discontinued its sales of the drug, called Actos, in France and Germany in June of this year after being pressured by drug regulators in those two countries.” View full resource at diabeticlive.com
Most Recently Shared on August 19, 2011 at 12:40 pm By:
Diabetes Drug Actos May Increase Risk of Bladder Cancer http://t.co/SWIrJob
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Bob Finn - Medical News Net
Bringing you the latest news from scientific meetings and the policy world. Check us out at www.internalmedicinenews.com
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
